Lamkin EN, Shimony S, Mehra S, Lane A, Taylor J. Real-world outcomes of venetoclax plus hypomethylating agents in BPDCN across treatment lines. haematol [Internet]. 2020Sep.10 [cited 2026Sep.13];. Available from: https://haematologica.org/article/view/14376